Earn Pharmacology CE Credit in an Easy way!

What Makes Our CE "Simply the Best!"

    • Concise up-to-date lectures with full slideshows
    • PowerPoint handouts for easy download
    • One month to complete from time of purchase
    • Fast forward/rewind capability so you can be sure to master the material

    • Full screen capability; perfect for tablet users
    • Portable: Carry with you on your smartphone or laptop
    • Access on your computer immediately
    • Obtain needed CE and pharmacology contact hours
    • One 5-item quiz
    • Three quiz attempts

Barkley & Associates, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 080518.

Provider approved by the California Board of Registered Nursing, Provider Number CEP 15436, for the specified number of contact hours.

All NP state regulatory agencies (i.e., State Boards of Nursing) and national certifying bodies (e.g., ANCC, AANP, AACN, PNCB, and NCC)
recognize and accept AANP CE credit for recertification! 

Advanced Pharmacology is an ever-changing field. Standard safety precautions must be followed, but as new research and clinical experience broaden our knowledge, changes in treatment and drug therapy may become necessary or appropriate. Readers are advised to check the most current product information provided by the manufacturer of each drug to be administered to verify the recommended dose, the method and duration of administration and contraindications. It is the responsibility of the licensed prescriber, relying on expertise and knowledge of the patient, to determine dosages and the best treatment for each individual patient. Neither Barkley & Associates nor any contributing authors assume any responsibility for any injury and/or damage to persons or property arising from this publication.

Pharmacokinetics determines how the body interacts with drugs in the process of absorption, distribution, metabolism, and excretion. This presentation will review these four processes, focusing on the key steps in each and the impact of certain disease states and other drugs or foods on pharmacokinetics.

In the second half of this presentation, an exploration into pharmacogenomics explains how each individual may have unique drug responses based on genetic variability in certain aspects of pharmacokinetic ability, particularly metabolism and excretion. These responses may affect drug efficacy or may predict adverse outcomes.

Included in this session are the following considerations:

  • Enterohepatic circulation in the metabolism of drugs
  • Variability of drug responses related to gender or age
  • Cytochrome P450 and drug interactions
  • Pregnancy and pediatric populations